Global Oncology Biosimilars Market Professional Survey Report 2016
- QYR586990
- 111 Pages
- June 2016
- Pharmaceuticals
Mainly covers the following product types
Orthopedic Braces
Other Orthotic Devices
The segment applications including
Segment regions including (the separated region report can also be offered)
USA
China
Europe
South America
Japan
Africa
The players list (Partly, Players you are interested in can also be added)
DJO Global,Inc.
Ossur hf.
Bauerfeind AG
DeRoyal Industries
BREG
THUASNE
Ottobock
BSN Medical GmbH & Co.KG
Bledsoe Brace Systems
Restorative Care of America,Inc.
Aspen Medical Products
Endolite
ORTEC
Huici Medical
SHULE
KEMAIJIEKANG
Jiaman
CSJBJZ
Luoyangboao
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - K MT and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/MT, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Oncology Biosimilars
1.1 Definition and Specifications of Oncology Biosimilars
1.1.1 Definition of Oncology Biosimilars
1.1.2 Specifications of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
1.2.1 Orthopedic Braces
1.2.2 Other Orthotic Devices
1.3 Applications of Oncology Biosimilars
1.4 Industry Chain Structure of Oncology Biosimilars
1.5 Industry Overview and Major Regions Status of Oncology Biosimilars
1.5.1 Industry Overview of Oncology Biosimilars
1.5.2 Global Major Regions Status of Oncology Biosimilars
1.6 Industry Policy Analysis of Oncology Biosimilars
1.7 Industry News Analysis of Oncology Biosimilars
2 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.1 Raw Material Suppliers and Price Analysis of Oncology Biosimilars
2.2 Equipment Suppliers and Price Analysis of Oncology Biosimilars
2.3 Labor Cost Analysis of Oncology Biosimilars
2.4 Other Costs Analysis of Oncology Biosimilars
2.5 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.6 Manufacturing Process Analysis of Oncology Biosimilars
3 Technical Data and Manufacturing Plants Analysis of Oncology Biosimilars
3.1 Capacity and Commercial Production Date of Global Oncology Biosimilars Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Oncology Biosimilars Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Oncology Biosimilars Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Oncology Biosimilars Major Manufacturers in 2015
4 Global Oncology Biosimilars Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Oncology Biosimilars Capacity and Growth Rate Analysis
4.2.2 2015 Oncology Biosimilars Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Oncology Biosimilars Sales and Growth Rate Analysis
4.3.2 2015 Oncology Biosimilars Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Oncology Biosimilars Sales Price
4.4.2 2015 Oncology Biosimilars Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Oncology Biosimilars Gross Margin
4.5.2 2015 Oncology Biosimilars Gross Margin Analysis (Company Segment)
5 Oncology Biosimilars Regional Market Analysis
5.1 USA Oncology Biosimilars Market Analysis
5.1.1 USA Oncology Biosimilars Market Overview
5.1.2 USA 2011-2016E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Oncology Biosimilars Sales Price Analysis
5.1.4 USA 2015 Oncology Biosimilars Market Share Analysis
5.2 China Oncology Biosimilars Market Analysis
5.2.1 China Oncology Biosimilars Market Overview
5.2.2 China 2011-2016E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Oncology Biosimilars Sales Price Analysis
5.2.4 China 2015 Oncology Biosimilars Market Share Analysis
5.3 Europe Oncology Biosimilars Market Analysis
5.3.1 Europe Oncology Biosimilars Market Overview
5.3.2 Europe 2011-2016E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Oncology Biosimilars Sales Price Analysis
5.3.4 Europe 2015 Oncology Biosimilars Market Share Analysis
5.4 South America Oncology Biosimilars Market Analysis
5.4.1 South America Oncology Biosimilars Market Overview
5.4.2 South America 2011-2016E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.4.3 South America 2011-2016E Oncology Biosimilars Sales Price Analysis
5.4.4 South America 2015 Oncology Biosimilars Market Share Analysis
5.5 Japan Oncology Biosimilars Market Analysis
5.5.1 Japan Oncology Biosimilars Market Overview
5.5.2 Japan 2011-2016E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Oncology Biosimilars Sales Price Analysis
5.5.4 Japan 2015 Oncology Biosimilars Market Share Analysis
5.6 Africa Oncology Biosimilars Market Analysis
5.6.1 Africa Oncology Biosimilars Market Overview
5.6.2 Africa 2011-2016E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Africa 2011-2016E Oncology Biosimilars Sales Price Analysis
5.6.4 Africa 2015 Oncology Biosimilars Market Share Analysis
6 Global 2011-2016E Oncology Biosimilars Segment Market Analysis (by Type)
6.1 Global 2011-2016E Oncology Biosimilars Sales by Type
6.2 Different Types Oncology Biosimilars Product Interview Price Analysis
6.3 Different Types Oncology Biosimilars Product Driving Factors Analysis
6.3.1 Orthopedic Braces Oncology Biosimilars Growth Driving Factor Analysis
6.3.2 Other Orthotic Devices Oncology Biosimilars Growth Driving Factor Analysis
7 Global 2011-2016E Oncology Biosimilars Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 Major Manufacturers Analysis of Oncology Biosimilars
8.1 DJO Global,Inc.
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 DJO Global,Inc. 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 DJO Global,Inc. 2015 Oncology Biosimilars Business Region Distribution Analysis
8.2 Ossur hf.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Ossur hf. 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Ossur hf. 2015 Oncology Biosimilars Business Region Distribution Analysis
8.3 Bauerfeind AG
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Bauerfeind AG 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Bauerfeind AG 2015 Oncology Biosimilars Business Region Distribution Analysis
8.4 DeRoyal Industries
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 DeRoyal Industries 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 DeRoyal Industries 2015 Oncology Biosimilars Business Region Distribution Analysis
8.5 BREG
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 BREG 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 BREG 2015 Oncology Biosimilars Business Region Distribution Analysis
8.6 THUASNE
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 THUASNE 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 THUASNE 2015 Oncology Biosimilars Business Region Distribution Analysis
8.7 Ottobock
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Ottobock 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Ottobock 2015 Oncology Biosimilars Business Region Distribution Analysis
8.8 BSN Medical GmbH & Co.KG
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 BSN Medical GmbH & Co.KG 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 BSN Medical GmbH & Co.KG 2015 Oncology Biosimilars Business Region Distribution Analysis
8.9 Bledsoe Brace Systems
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Bledsoe Brace Systems 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Bledsoe Brace Systems 2015 Oncology Biosimilars Business Region Distribution Analysis
8.10 Restorative Care of America,Inc.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Restorative Care of America,Inc. 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Restorative Care of America,Inc. 2015 Oncology Biosimilars Business Region Distribution Analysis
8.11 Aspen Medical Products
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Aspen Medical Products 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Aspen Medical Products 2015 Oncology Biosimilars Business Region Distribution Analysis
8.12 Endolite
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Endolite 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Endolite 2015 Oncology Biosimilars Business Region Distribution Analysis
8.13 ORTEC
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 ORTEC 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 ORTEC 2015 Oncology Biosimilars Business Region Distribution Analysis
8.14 Huici Medical
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Huici Medical 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Huici Medical 2015 Oncology Biosimilars Business Region Distribution Analysis
8.15 SHULE
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 SHULE 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 SHULE 2015 Oncology Biosimilars Business Region Distribution Analysis
8.16 KEMAIJIEKANG
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 KEMAIJIEKANG 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 KEMAIJIEKANG 2015 Oncology Biosimilars Business Region Distribution Analysis
8.17 Jiaman
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Jiaman 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Jiaman 2015 Oncology Biosimilars Business Region Distribution Analysis
8.18 CSJBJZ
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 CSJBJZ 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 CSJBJZ 2015 Oncology Biosimilars Business Region Distribution Analysis
8.19 Luoyangboao
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Luoyangboao 2015 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Luoyangboao 2015 Oncology Biosimilars Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Oncology Biosimilars Consumption Forecast
9.2.2 China 2016-2021 Oncology Biosimilars Consumption Forecast
9.2.3 Europe 2016-2021 Oncology Biosimilars Consumption Forecast
9.2.4 South America 2016-2021 Oncology Biosimilars Consumption Forecast
9.2.5 Japan 2016-2021 Oncology Biosimilars Consumption Forecast
9.2.6 Africa 2016-2021 Oncology Biosimilars Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Oncology Biosimilars Marketing Model Analysis
10.1 Oncology Biosimilars Regional Marketing Model Analysis
10.2 Oncology Biosimilars International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Oncology Biosimilars by Regions
10.4 Oncology Biosimilars Supply Chain Analysis
11 Consumers Analysis of Oncology Biosimilars
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Oncology Biosimilars
12.1 New Project SWOT Analysis of Oncology Biosimilars
12.2 New Project Investment Feasibility Analysis of Oncology Biosimilars
13 Conclusion of the Global Oncology Biosimilars Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
